| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 3.4K | 3.1% | 2.0% |
| Total Income | 3.5K | 3.0% | 1.9% |
| Expenditure | 3.7K | 0.4% | 1.3% |
| PBT | -2.0K | 1731.8% | 1637.1% |
| Net Profit | -2.1K | 2966.7% | 4218.4% |
| OPM | -45.46% | 53.66pp | 53.21pp |
| NPM | -60.77% | 58.85pp | 59.39pp |
| EPS | 83.68 | 2192.6% | 2785.5% |
Tata Chemicals FY26: Revenue at ₹14,584 Cr, Down 2%
04 May 2026 · 4 May, 6:41 pm
Summary
Tata Chemicals Limited reported a challenging Q4FY26 and full financial year FY26, with consolidated revenue from operations for Q4FY26 at ₹ 3,438 Cr, a 2% year-on-year decline, and full-year revenue at ₹ 14,584 Cr, also down 2% from FY25. Consolidated EBITDA for Q4FY26 decreased to ₹ 274 Cr from ₹ 327 Cr in Q4FY25, primarily due to subdued pricing and increased fixed costs. The company recognized significant exceptional charges, including a ₹ 1,837 Cr impairment of goodwill in the US during Q4FY26. Despite the challenging external environment characterized by supply overhang and geopolitical tensions, the standalone performance was supported by higher volumes and disciplined cost management. Management emphasized a focus on safeguarding margins, preserving cash flows, and maintaining a resilient balance sheet, while strategic investments like the Novabay acquisition and Mithapur plant debottlenecking position the company for long-term growth.
Key Highlights
- 1
Consolidated revenue from operations for Q4FY26 stood at ₹ 3,438 Cr, marking a 2% decline compared to Q4FY25, primarily due to lower realization offset by higher volumes in India.
- 2
Consolidated EBITDA for Q4FY26 was ₹ 274 Cr, down from ₹ 327 Cr in Q4FY25, reflecting subdued pricing across all geographies and increased fixed costs.
- 3
An exceptional charge of ₹ 1,837 Cr was recognized in Q4FY26 due to impairment of goodwill in the US, alongside a ₹ 159 Cr write-off of deferred tax assets.
- 4
For the full financial year FY26, consolidated revenue from operations was ₹ 14,584 Cr, a 2% decrease from FY25, driven by pricing pressure and lower volumes in most regions.
- 5
The Board recommended a dividend of ₹ 11 per share for FY26.
- 6
The acquisition of Novabay Pte. Limited, Singapore, was successfully completed on March 19, 2026, aligning with the company's strategy to expand into high-margin specialty chemicals.
- 7
Mithapur facility (India) achieved an annual production milestone of 1 MTPA of Soda Ash during FY26, and the Board approved a ₹100 crore investment to debottleneck salt capacity at the plant.
Management Comments
R. Mukundan
During Q4FY26 the global soda ash markets remained adequately supplied and the supply overhang continue to exert pressure on pricing. The challenging external environment amid ongoing geopolitical tensions in the Middle East led to uncertainty and limited visibility on any immediate change in market conditions. Despite the challenging external environment, the Company’s standalone performance has been supported by higher volumes and disciplined cost management, resulting in a resilient operating performance. Mithapur facility (India) achieved production of 1 MTPA of Soda Ash during FY26. However, the Company’s consolidated performance has been sharply impacted by continuing unsustainable unremunerative prices across geographies particularly in Southeast Asia. In US, impairment charge of ₹ 1,837 Cr of goodwill & ₹ 182 Cr of deferred tax assets write-off recognized amidst the current soda ash export market conditions. We successfully completed the acquisition of Novabay Pte. Limited, Singapore during the quarter, as announced earlier. This acquisition aligns with our strategy of expanding high-margin specialty chemicals and strengthening our presence in key global markets. It enhances our ability to offer differentiated, value-added solutions and supports our long-term growth agenda. The Board also approved a ₹100 crore investment to debottleneck salt capacity at our Mithapur plant by 82,500 TPA. This will strengthen our core consumer products portfolio and support long-term, sustainable growth while meeting rising demand for high-quality iodised salt. In the midst of a challenging and volatile operating environment, our focus remains resolutely on safeguarding margins, preserving cash flows, and maintaining a strong and resilient balance sheet. We are navigating this phase with prudence and disciplined capital deployment. These actions are aimed at reinforcing the Company’s financial strength and positioning us to emerge from the current cycle with sustained stability and long-term value creation for our investors.
Informational and educational content only. Not investment advice.